[Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation]
Related Experiment Video
Updated: Jul 14, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
Janina Priluckiene1, Indre Kriukelyte, Mindaugas Jurgutis
1Department of Nephrology and Dialysis, Seamen's Hospital of Klaipeda, Klaipeda, Lithuania. nefrologija@junet.lt
Insights
Chronic graft-versus-host disease, a late complication of allogeneic stem cell transplant, can affect kidneys, presenting as nephrotic syndrome. This case highlights kidney biopsy findings and successful treatment with immunosuppressants.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Allogeneic hematopoietic stem cell transplantation (HSCT) can lead to early (<100 days) and late (>100 days) complications.
- Chronic graft-versus-host disease (cGVHD) is a frequent late complication (60-80% of survivors), primarily affecting skin, mucous membranes, GI tract, and liver.
- Kidneys are not typically considered a target organ for cGVHD, though renal involvement has been reported.
Observation:
- A patient developed nephrotic syndrome three years after HSCT.
- Kidney biopsy revealed membranous nephropathy as the cause of nephrotic syndrome.
- This presentation suggests a potential manifestation of cGVHD in the kidneys.
Findings:
- The patient's nephrotic syndrome was attributed to membranous nephropathy.
- Treatment with cyclosporine and methylprednisolone resulted in a significant reduction in albuminuria.
- This indicates a positive response to immunosuppressive therapy.
Implications:
- This case expands the understanding of potential cGVHD target organs beyond traditional sites.
- It emphasizes the importance of considering cGVHD in patients with unexplained nephrotic syndrome post-HSCT.
- Early diagnosis and treatment of renal cGVHD may improve patient outcomes and reduce morbidity.
Abstract:
Complications of allogenic hematopoietic stem cell transplantation that occur in the first 100 days are considered early and those that begin 100 days after are considered late complications. Chronic graft-versus-host disease is the most common late complication of allogenic hematopoietic cell transplantation, which occurs in 60-80% of long-term survivors and causes significant morbidity and mortality. It is well known that it affects primarily the skin, mucous membranes, cells in the gastrointestinal tract and liver. The kidneys are not considered a target organ for chronic graft-versus-host disease in humans, although renal involvement in patients with chronic graft-versus-host disease, presenting as nephrotic syndrome, has been reported in patients who underwent allogenic transplantation. We present a case of chronic graft-versus-host disease that manifested as nephrotic syndrome after hematopoietic cell transplantation performed 3 years ago. Kidney biopsy revealed membrane nephropathy. Treatment with cyclosporine and methylprednisolone significantly reduced albuminuria.
Related Concept Videos
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease II: Clinical Manifestations
Cell-mediated Immune Responses